Rasmanis G et al. |
Prostacyclin production in myocardial infarction in the acute phase and during follow-up. |
1991 |
J. Intern. Med. |
pmid:1997639
|
Morrow JD et al. |
Increased formation of thromboxane in vivo in humans with mastocytosis. |
1999 |
J. Invest. Dermatol. |
pmid:10417625
|
Mastrogiannis DS et al. |
Cocaine decreases urinary prostacyclin release in pregnancy: correlation with uterine and umbilical Doppler velocimetry. |
2003 |
J. Matern. Fetal. Neonatal. Med. |
pmid:15061316
|
Kuehl PG et al. |
Systemic production of prostacyclin and thromboxane A2 does not correlate with patency of the ductus arteriosus in very low birth weight infants. |
1986 |
J. Pediatr. |
pmid:3519915
|
Brown NJ et al. |
Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin. |
1996 |
J. Pharmacol. Exp. Ther. |
pmid:8930174
|
Catella-Lawson F et al. |
Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. |
1999 |
J. Pharmacol. Exp. Ther. |
pmid:10215647
|
Capone ML et al. |
Human pharmacology of naproxen sodium. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17473175
|
Neiman J et al. |
Effects of a small dose of ethanol and calcium carbimide-induced acetaldehyde intoxication on human platelet aggregation, associated thromboxane formation and urinary excretion of 2,3-dinor-6-keto prostaglandin F1 alpha. |
1987 |
J. Toxicol. Clin. Toxicol. |
pmid:3612897
|
Lin JS et al. |
The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence. |
1992 |
J. Urol. |
pmid:1635125
|
Hashimoto K et al. |
Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness. |
2004 |
J. Virol. |
pmid:15367596
|